Current cancer therapeutics / (Record no. 9127)

MARC details
000 -LEADER
fixed length control field 02888cas a2200505 a 4500
001 - CONTROL NUMBER
control field 11438084
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230905135631.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 940121c19949999pauar f 0 a0eng c
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 94644516
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781573401760
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1573401765
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1074-2816
ISSN-L 1074-2816
Source 1
040 ## - CATALOGING SOURCE
Original cataloging agency BUL
Language of cataloging eng
Transcribing agency BUL
Modifying agency BUL
Description conventions rda
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QZ 267 K598c 2001
Item number K598c 2001
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99406
Edition number 20
Item number KIR
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Kirkwood, John M.
210 0# - ABBREVIATED TITLE
Abbreviated title Curr. cancer ther.
222 #0 - KEY TITLE
Key title Current cancer therapeutics
245 00 - TITLE STATEMENT
Title Current cancer therapeutics /
Statement of responsibility, etc. John M. Kirkwood, Michael T. Lotze, Joyce M. Yasko
250 ## - EDITION STATEMENT
Edition statement 4th edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Philadelphia, PA :
Name of publisher, distributor, etc. Current Medicine,
Date of publication, distribution, etc. ©1994-
300 ## - PHYSICAL DESCRIPTION
Extent volumes :
Other physical details ill. ;
Dimensions 28 cm
310 ## - CURRENT PUBLICATION FREQUENCY
Current publication frequency Annual
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Media type code n
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Carrier type code nc
Source rdacarrier
362 0# - DATES OF PUBLICATION AND/OR SEQUENTIAL DESIGNATION
Dates of publication and/or sequential designation 1st ed.-
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents <br/>1: Agents.<br/> 1. Alkylating and Platinating Agents.<br/> 2. Antimetabolic Agents.<br/> 3. Biologic Agents.<br/> 4. Hormonal Agents.<br/> 5. Tubulin-Targeting Drugs <br/><br/>2: Specific Neoplasms and Therapeutic Protocols.<br/> 6. Breast Cancer.<br/> 7. Upper Gastrointestinal Cancer.<br/> 8. Lower Gastrointestinal Cancer.<br/> 9. Head and Neck Cancer.<br/>10. Lung Cancer.<br/> 11. Melanoma and Other Tumors of the Skin.<br/> 12. Sarcomas.<br/> 13. Genitourinary Cancer.<br/> 14. Gynecologic Malignancies.<br/> 15. Malignant Glioma.<br/> 16. Endocrine Cancer.<br/> 17. Leukemia.<br/> 18. Hodgkin's Disease.<br/> 19. Non-Hodgkin's Lymphoma.<br/> 20. Myeloma.<br/> 21. Malignant Effusions in the Chest.<br/> 22. Carcinoma of Unknown Primary.<br/> 23. Aids-Related Malignancies. <br/><br/>3: Supportive Care.<br/> 24. Palliative Care.<br/> 25. Myelosuppression.<br/> 26. Gastrointestinal Toxicities.<br/> 27. Renal and Metabolic Complications.<br/> 28. Pulmonary and Cardiovascular Complications of Cancer Therapy.<br/> 29. Neurotoxicities.<br/> 30. Evaluation of Quality of Life in Cancer Clinical Trials.<br/> 31. Systemic Manifestations of Cancer and Management of Systemic Paraneoplastic Syndromes.<br/> 32. Malnutrition.<br/><br/>4: Clinical Trial Data Collection.<br/> 33. Clinical Trials: Monitoring and Reporting of Toxicities, and Evaluating Tumor Response.<br/> 34. Synoptic Pathology Reports.<br/>
590 ## - LOCAL NOTE (RLIN)
Local note SERBIB/SERLOC merged record
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer
General subdivision Treatment
Form subdivision Periodicals.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision therapy.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer
General subdivision Treatment.
Source of heading or term fast
655 #2 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Handbook.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Periodicals.
Source of term fast
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Periodicals.
Source of term lcgft
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Lotze, Michael T.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Yasko, Joyce M.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Online version:
Title Current cancer therapeutics
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book Open Access
Edition 4th edition
Classification part QZ 267 K598c 2001
Item part 1
Call number prefix QZ 267
Call number suffix K598c 2001
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Dewey Decimal Classification     Health Sciences Library Health Sciences Library 01/16/2022 Donation 00242   QZ 267 K598c 2001 MBAL22010434 01/16/2022 1 01/16/2022 Book Open Access